Prospects for Neuroprotective Therapies in Glaucoma: Drug Targets and Emerging Clinical Strategies. [PDF]
Rho S, Williams PA.
europepmc +1 more source
ABSTRACT Background The recent approval of disease‐modifying therapies (DMTs) for early Alzheimer's disease (AD) marks a major shift in clinical practice. Biomarker confirmation of amyloid pathology is now required alongside clinical assessment, and blood‐based tests are improving accessibility.
Tim Van Langenhove +31 more
wiley +1 more source
Modulation of NMDA Receptor and TRPM4 Activity in Hippocampal Neurons with the NMDA Receptor/TRPM4 Interface Inhibitor Brophenexin. [PDF]
Casby J +3 more
europepmc +1 more source
Clonidine Inhibits Interictal-like Epileptiform Events in Prefrontal Cortex Pyramidal Neurons. [PDF]
Kołba W, Herbst D, Szulczyk B.
europepmc +1 more source
Potential Neuroprotective Effects of Docosahexaenoic Acid on Glutamate-Induced Neurotoxicity: A Systematic Review of Pre-Clinical Studies. [PDF]
Rusleen MHR +4 more
europepmc +1 more source
Case Report: Oral glutamatergic augmentation for trauma-related disorders with fluoxetine-/bupropion-potentiated dextromethorphan ± piracetam: a four-patient case series. [PDF]
Cheung N.
europepmc +1 more source
Magnesium Transporter SLC41A1 Links Magnesium Homeostasis to NMDA Receptor-Related Synaptic Dysfunction: A Transdiagnostic Therapeutic Target for Neuropsychiatric Disorders. [PDF]
Chen X, Deng W, Chen X, Yu Y.
europepmc +1 more source
Müller glia derived EVs promote neurite recovery of an enriched population of retinal ganglion like cells derived from hESC retinal organoids after damage. [PDF]
Eastlake K +6 more
europepmc +1 more source

